levofloxacin has been researched along with Shock, Septic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, LJ; Wang, DL; Zhao, LD; Zhou, MJ | 1 |
| Hibi, A; Kumano, Y | 1 |
| Bernard, S; Lee, K; Pakyz, A; Stevens, M; Vaughan, D | 1 |
| Chen, FL; Hsu, CW; Jean, SS; Lee, WS; Ou, TY | 1 |
| Etoh, Y; Furusyo, N; Hayashi, J; Kishihara, Y; Kumade, E; Mitsumoto-Kaseida, F; Murata, M; Takeshima, N | 1 |
| Deis, AS; Simpson, SQ; Whiles, BB | 1 |
| Chi, CL; Chuang, TY; Hsueh, PR; Lee, SW; Lin, CJ; Lin, TL; Liu, AY; Wang, JT | 1 |
| Fujishima, Y; Kato, R; Matsuura, T; Obara, W; Sato, K; Shimaya, R; Suzuki, Y; Tokiwa, S | 1 |
| Chiu, CT; Lai, CH; Lai, YF; Lin, HH; Wei, YF | 1 |
| Chen, WJ; Chuang, CP; Chuang, TY; Hsueh, PR; Jong, YS; Lee, SW; Lin, CJ | 1 |
| Cirioni, O; Ghiselli, R; Giacometti, A; Kamysz, W; Kasprzykowski, F; Mackiewicz, Z; Mocchegiani, F; Orlando, F; Paggi, AM; Saba, V; Scalise, G | 1 |
11 other study(ies) available for levofloxacin and Shock, Septic
| Article | Year |
|---|---|
Septic shock caused by Rhizobium radiobacter in an elderly woman: A case report.
Topics: Aged, 80 and over; Agrobacterium tumefaciens; Anti-Bacterial Agents; Cefoperazone; Disease Progression; Drug Therapy, Combination; Female; Humans; Levofloxacin; Shock, Septic; Sulbactam | 2019 |
Sphingobacterium spiritivorum bacteremia due to cellulitis in an elderly man with chronic obstructive pulmonary disease and congestive heart failure: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cellulitis; Gram-Negative Bacterial Infections; Heart Failure; Humans; Levofloxacin; Male; Meropenem; Pulmonary Disease, Chronic Obstructive; Shock, Septic; Sphingobacterium; Thienamycins; Treatment Outcome | 2017 |
Adequacy of empiric gram-negative coverage for septic patients at an academic medical center.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Gram-Negative Bacteria; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Shock, Septic; Virginia; Young Adult | 2019 |
Co-infection with Orientia tsutsugamushi and Mycoplasma pneumoniae in a traveler.
Topics: Humans; Leptospirosis; Levofloxacin; Male; Ofloxacin; Penicillins; Protein C; Respiratory Insufficiency; Scrub Typhus; Shock, Septic | 2015 |
A case of lobar pneumonia and sepsis with death caused by invasive Klebsiella rhinoscleromatis infection.
Topics: Aged; Anti-Bacterial Agents; Blood Culture; C-Reactive Protein; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Lung; Male; Pneumonia, Bacterial; Shock, Septic; Tomography, X-Ray Computed | 2016 |
Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Comorbidity; Disease Progression; Female; Hospital Mortality; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Sex Factors; Shock, Septic; Time Factors; Time-to-Treatment; Vasoconstrictor Agents | 2017 |
Rapidly fatal bacteremic pneumonia caused by Klebsiella pneumoniae with K1 hypermucoviscosity phenotype in a previously healthy young man receiving levofloxacin treatment.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacteremia; Bacterial Capsules; Bacterial Typing Techniques; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Multiple Organ Failure; Ofloxacin; Phenotype; Pneumonia, Bacterial; Polysaccharides, Bacterial; Serotyping; Shock, Septic; Young Adult | 2009 |
[Septic shock due to fluoroquinolone-resistant Escherichia coli after trans-rectal prostate needle biopsy].
Topics: Biopsy, Needle; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Postoperative Complications; Rectum; Shock, Septic | 2010 |
Successful treatment of septic shock and respiratory failure due to leptospirosis and scrub typhus coinfection with penicillin, levofloxacin, and activated protein C.
Topics: Anti-Infective Agents; Antibodies, Bacterial; Humans; Leptospira; Leptospirosis; Levofloxacin; Male; Middle Aged; Ofloxacin; Orientia tsutsugamushi; Penicillins; Protein C; Respiratory Insufficiency; Scrub Typhus; Shock, Septic | 2012 |
Rapidly fatal community-acquired pneumonia due to Klebsiella pneumoniae complicated with acute myocarditis and accelerated idioventricular rhythm.
Topics: Accelerated Idioventricular Rhythm; Acidosis, Lactic; Acute Disease; Community-Acquired Infections; Electrocardiography; Fatal Outcome; Humans; Intensive Care Units; Klebsiella pneumoniae; Levofloxacin; Male; Middle Aged; Myocarditis; Ofloxacin; Pneumonia, Bacterial; Shock, Septic | 2012 |
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Drug Therapy, Combination; Injections, Intraperitoneal; Levofloxacin; Male; Ofloxacin; Polymyxin B; Rats; Rats, Wistar; Shock, Septic | 2002 |